C&EN’s Year in Pharma 2022: Oncology, Big Pharma top out US FDA’s 2022 approvals

Gene therapies, novel psoriasis drugs, and a Botox rival are among notable green-lit products

Source: Chemical and Engineering News - December 2, 2022 Category: Chemistry Authors: Gina Vitale Source Type: research